RELPAX Tablets should not be given to patients with ischemic heart disease (e.g., angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have symptoms, or findings consistent with ischemic heart disease, coronary artery vasospasm, including Prinzmetal's variant angina, or other significant underlying cardiovascular disease (see WARNINGS).
RELPAX Tablets should not be given to patients with cerebrovascular syndromes including (but not limited to) strokes of any type as well as transient ischemic attacks (see WARNINGS).
RELPAX Tablets should not be given to patients with peripheral vascular disease including (but not limited to) ischemic bowel disease (see WARNINGS).
Because RELPAX Tablets may increase blood pressure, it should not be given to patients with uncontrolled hypertension (see WARNINGS).
RELPAX Tablets should not be administered to patients with hemiplegic or basilar migraine.
RELPAX Tablets should not be used within 24 hours of treatment with another 5HT1 agonist, an ergotamine-containing or ergot-type medication such as dihydroergotamine (DHE) or methysergide.
RELPAX Tablets should not be used in patients with known hypersensitivity to eletriptan or any of its inactive ingredients.
RELPAX Tablets should not be given to patients with severe hepatic impairment.
- Relpax Information for Consumers
- Relpax Information for Healthcare Professionals (includes dosage details)
- Side Effects of Relpax (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 14 Mar 2011 • 1 answer
Posted 4 Nov 2011 • 2 answers
Has anyone with clinical depression,been hospitalized with stroke like symptoms after taking Relpax?
Posted 29 Mar 2012 • 3 answers
Posted 3 Feb 2016 • 1 answer
Posted 27 Feb 2017 • 1 answer